Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/30/2003WO2003044193A2 Nucleic acid linkers and use thereof in gene synthesis
05/30/2003WO2003044190A1 Environmental stress-responsive promoters and genes encoding transcriptional factor
05/30/2003WO2003044189A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same
05/30/2003WO2003044188A1 Method of inhibiting gene expression
05/30/2003WO2003044187A2 Emulsion compositions
05/30/2003WO2003044186A2 Novel gene cluster of pederin biosynthesis genes
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003044183A1 Interleukin-2 gene transferred lymphokine activated killer cells
05/30/2003WO2003044182A1 CELLS EXPRESSING gob-5 AND USE THEREOF
05/30/2003WO2003044177A2 Multiplex pcr
05/30/2003WO2003044176A2 Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044168A2 Facilitation of rna interference
05/30/2003WO2003044167A2 Antisense modulation of human fxr expression
05/30/2003WO2003044166A2 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER
05/30/2003WO2003044165A2 Genetically modified bacterial strains and novel vectors for use in expressing and assaying natural products
05/30/2003WO2003044163A2 Antisense modulation of toll-like receptor 4 expression
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044051A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003WO2003044050A1 Method for producing a recombinant protein using pollen
05/30/2003WO2003044049A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003WO2003044048A2 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003WO2003044047A2 Virulence proteins of the genus yersinia and uses thereof
05/30/2003WO2003044036A1 Tumor specific monoclonal antibodies
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043654A1 Recombinant vaccinia virus vaccine
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043648A2 Sfcyr iib or sfcyr iii for the treatment of auto-immune diseases
05/30/2003WO2003043631A2 Method for identification of tumor targeting enzymes
05/30/2003WO2003043588A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043581A2 Composition and method for modulating bar/fxr receptor activity
05/30/2003WO2003043580A2 Methods for identifying and validating potential drug targets
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003043565A2 Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
05/30/2003WO2003043415A1 Exogenous protein expression system in an avian system
05/30/2003WO2003043411A2 Manipulation of the phenolic acid content and digestibility of plant cell walls
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003026691A3 Use of hmgb1 for the activation of dendritic cells
05/30/2003WO2003025176A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
05/30/2003WO2003025164A3 A gene encoding cyclododecanone monooxygenase
05/30/2003WO2003022439A3 Zone heating of specimen carriers
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003014341A3 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof
05/30/2003WO2003014327A3 Stress-related polynucleotides and polypeptides in plants
05/30/2003WO2003012123A3 Antisense modulation of dual specific phosphatase 9 expression
05/30/2003WO2003011200A3 Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2003002735A3 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002098891A3 GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002095363A3 Methods for attenuation of virulence in bacteria
05/30/2003WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor
05/30/2003WO2002094123A3 Method of preparing a dought with an enzime
05/30/2003WO2002092132A3 Microparticles and methods for delivery of recombinant viral vaccines
05/30/2003WO2002088176A3 Genes and proteins for the biosynthesis of polyketides
05/30/2003WO2002086068A3 Methods for producing recombinant coronavirus
05/30/2003WO2002078426A3 Final segregation of male meiotic products in plants
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002074952A3 Nucleic acid which is stabilised against decomposition
05/30/2003WO2002074929A3 Evolving new molecular function
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis
05/30/2003WO2002057416B1 Improved biochip
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051992A3 21163, a novel human prolyl oligopeptidase and uses therefor
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof
05/30/2003WO2002048372A3 Target enzymes
05/30/2003WO2002047717A9 Targeted enzyme prodrug therapy
05/30/2003WO2002044376A3 Modulation of gene expression using insulator binding proteins
05/30/2003WO2002044339A3 Nucleic acid amplification methods
05/30/2003WO2002041839A3 Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein
05/30/2003WO2002040710A3 Method for detecting methylation states for a toxicological diagnostic
05/30/2003WO2002038608A9 Methods of screening for ltrpc2 modulators
05/30/2003WO2002034291A3 Compositions and methods for treating hematologic malignancies and multiple drug resistance
05/30/2003WO2002031025A9 Biodegradable poly(beta-amino esters) and uses thereof
05/30/2003WO2002030962A3 Metal binding proteins, recombinant host cells and methods
05/30/2003WO2002020790A9 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
05/30/2003WO2002018425A3 '47324', a novel g-protein and uses therefor
05/30/2003WO2002012273A3 Herbicide target genes and methods
05/30/2003WO2002010182A3 Methods for isolating one strand of a double-stranded nucleic acid
05/30/2003WO2002008382A3 Controlled environment agriculture bioreactor for heterologous protein production
05/30/2003WO2002008270A3 A mort-1 interacting protein, its preparation and use
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001096381A3 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
05/30/2003WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity
05/30/2003WO2001052874A9 Intra-tumoral administration of il-12 encoding nucleic acid molecules
05/30/2003CA2492536A1 Postsynaptic proteins
1 ... 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 ... 4023